Bodybuilding Supplements Greece
Stock information for MSLP, HLF, and RELV
crwefinancelogo2
signup3m
MusclePharm Corporation (OTC:MSLP), One of the fastest growing nutritional supplement companies in the United States recently reported a distribution agreement with Sportika Export Inc., a leading sports nutrition distributor, to over 130 countries internationally.
We are very excited about the opportunity to expand distribution into over 130 markets as we continue to grow MusclePharm’s international brand presence, said Brad Pyatt, MusclePharm’s Chief Executive Officer. Creating a strategic partnership with Sportika Export will allow us to broaden our nutritional product formulations availability in the global healthy living and wellness industry as we strive to increase sales and profitability long-term.
MusclePharm’s multiple products are currently available in 1,200 of the top GNC stores in the United States, as well as over 450 Vitamin Shoppe stores. MusclePharm’s award-winning products Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon and Shred Matrixare also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.
It’s been years since Sportika Export has seen the level of interest from distributors abroad that MusclePharm has generated. We’re excited to be part of their huge growth potential and bring it to the 130 plus countries we deal with, commented Richard White, Jr., Sportika’s President. We feel that MusclePharm is the next BIG thing in the Sports Nutrition Industry. Their innovation with products and marketing is going to take them to the top. We look forward to a long lasting successful relationship with MusclePharm.
MusclePharm will begin to distribute products with Sportika Export in September of 2010.
MSLP is a fast-growing developer and manufacturer of safe, scientifically approved nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists.
Herbalife Ltd. (NYSE:HLF) recently reported the appointment of Manolis Leontzakos as country director, Greece and Cyprus, responsible for the growth and profitability of the countries, and for working with Herbalife independent distributors to grow the businesses in a sustainable manner. He reports to the company’s vice president, East Central Europe and Middle East, Edyta Kurek.
Leontzakos has spent the majority of his career in fast-moving consumer goods. He started with Proctor and Gamble, holding a variety of sales, business development and market strategy planning roles in Greece and at its European headquarters in Switzerland. He then moved to Carrefour Marinopoulos Hypermarkets, a joint venture in Greece of Europe’s No. 1 retailer Carrefour, in 2006, where he was ultimately country sales development director for the fast-moving consumer goods categories. He joined Herbalife from Lafarge, a French worldwide building materials company, where Leontzakos worked since 2007 as marketing and strategy director.
HLF is a global network marketing company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 73 countries through a network of approximately 2.1 million independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children.
Reliv International, Inc. (Nasdaq:RELV) is a developer, manufacturer and marketer of a proprietary line of nutritional supplements. Reliv supplements address essential daily nutrition, weight loss and targeted solutions such as energy and performance enhancement, digestive health, women’s health and anti-aging. Reliv sells its products through an international network marketing system of approximately 64,000 independent distributors.
Reliv International, Inc. a nutritionand direct selling company, recently reported consolidated net sales of $18.8 million for the second quarter
of 2010, compared to net sales of $20.1 million in the second quarter of last year. International sales rose 18.7 percent compared to the same quarter in 2009, but U.S. sales were down 9.5 percent in the quarter.
Net income was $206,000 compared to net income of $410,000 in the second quarter of last year. Diluted earnings per share totaled $0.02 in the second quarter this year compared to $0.03 in the same quarter last year.
U.S. sales for the quarter totaled approximately $15.9 million compared to $17.6 million in the second quarter of 2009. Sales outside of the U.S. rose to approximately $2.9 million compared to net sales of approximately $2.4 million in last year’s second quarter. In local currencies,international sales rose 11.3 percent in the second quarter compared to the same quarter last year. Sales outside of the U.S. account for 15 percent of net sales.
http://crwefinance.com/img/crwefinance_new_buscard2.jpg
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).
About the Author
Dimitris Papantonis Interview (PhD Team Hellas) (Part 1/2) [HD]